Key result
Corin-based therapies show potential to treat heart failure by enhancing natriuretic peptide activity.
Why the study?
Impaired natriuretic peptide processing contributes to sodium and fluid retention in heart failure, warranting an evaluation of corin in sodium homeostasis, vascular remodeling, and therapeutic potential.
Corin is a key mediator in ANP activation, making it a potential therapeutic target for managing sodium and fluid retention in heart failure.
Should not change HF practice yet; extends corin pathway insights but leaves clinical translation open.
Atrial natriuretic peptide (ANP) is a crucial element of the cardiac endocrine function that promotes natriuresis, diuresis, and vasodilation, thereby protecting normal blood pressure and cardiac function. Corin is a type II transmembrane serine protease that is highly expressed in the heart, where it converts the ANP precursor to mature ANP. Corin deficiency prevents ANP activation and causes hypertension and heart disease. In addition to the heart, corin is expressed in other tissues, including those of the kidney, skin, and uterus, where corin-mediated ANP production and signaling act locally to promote sodium excretion and vascular remodeling. These results indicate that corin and ANP function in many tissues via endocrine and autocrine mechanisms. In heart failure patients, impaired natriuretic peptide processing is a common pathological mechanism that contributes to sodium and body fluid retention. In this review, we discuss most recent findings regarding the role of corin in non-cardiac tissues, including the kidney and skin, in regulating sodium homeostasis and body fluid excretion. Moreover, we describe the molecular mechanisms underlying corin and ANP function in supporting orderly cellular events in uterine spiral artery remodeling. Finally, we assess the potential of corin-based approaches to enhance natriuretic peptide production and activity as a treatment of heart failure.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) conducted a review in Heart failure. Corin was evaluated. Corin mediates sodium homeostasis and vascular remodeling across multiple tissues, suggesting corin-based approaches to enhance natriuretic peptide activity may serve as a treatment for heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: